# Similarity-Based Profiling of Hydrazone-Containing Scaffolds Active Against Leishmania Amastigotes

**Authors:** Rita Yanka Pereira da Silva, Jheynne Laina Alves de Lima, Samara Beatriz de Abreu Pinto, Lamark Carlos I., Alessandro Kappel Jordão, Euzébio Guimarães Barbosa

PMC · DOI: 10.1021/acsomega.5c05276 · ACS Omega · 2025-10-22

## TL;DR

This review explores hydrazone compounds that fight Leishmania parasites by analyzing their 3D shapes to guide drug discovery.

## Contribution

The study introduces a shape-based molecular alignment strategy for identifying anti-leishmanial compounds.

## Key findings

- Hydrazone compounds with specific 3D electroshape properties show strong activity against Leishmania amastigotes.
- Molecular alignment techniques reveal key structural features linked to anti-leishmanial efficacy.
- Combining computational and experimental methods improves understanding of compound optimization.

## Abstract

This review explores
the potential of hydrazone-containing scaffolds
as anti-leishmanial agents with a particular focus on their activity
against intracellular Leishmania amastigotes.
Through a strategy centered on the 3D electroshape properties of compounds,
structural analysis goes beyond the traditional functional group-based
approach, employing molecular alignment techniques to identify key
structural features associated with anti-leishmanial activity. This
review systematically compiled data from previous studies, highlighting
compounds with promising in vitro activity. Structural comparisons
using molecular overlays have enabled the identification of promising
compounds and the exploration of their potential mechanisms of action.
The integration of computational and experimental approaches provides
valuable insights into the rational optimization of hydrazone scaffolds
with the aim of improving efficacy, bioavailability, and safety. However,
complete elucidation of the precise molecular targets and mechanisms
of action remains a crucial challenge for future research. In summary,
this review highlights the potential of hydrazone-containing compounds
as a basis for developing novel therapeutic agents against leishmaniasis
by utilizing a shape-based molecular alignment strategy to drive drug
discovery efforts.

## Linked entities

- **Diseases:** leishmaniasis (MONDO:0011989)
- **Species:** Leishmania (taxon 5658)

## Full-text entities

- **Diseases:** leishmaniasis (MESH:D007896)
- **Chemicals:** Hydrazone (MESH:D006835)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12593058/full.md

## Figures

20 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12593058/full.md

## References

84 references — full list in the complete paper: https://tomesphere.com/paper/PMC12593058/full.md

---
Source: https://tomesphere.com/paper/PMC12593058